Pagui ECK, Brant SB, Svendsen K, Frigessi A, Helland Å, Thoresen S, Jonasson C (2025)
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pharmacoepidemiol Drug Saf, 34 (7), e70181
DOI 10.1002/pds.70181, PubMed 40552731

Garcia-Foncillas J, Bayle A, Arnold D, Avouac B, Awada A, de la Cruz-Merino L, Helland Å, Lassen U, Laurent-Puig P, Normanno N, Rohrberg K, Taieb J, Stenzinger A (2025)
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
Future Oncol, 21 (14), 1745-1752
DOI 10.1080/14796694.2025.2501523, PubMed 40340714

Hektoen HH, Tsuruda KM, Brustugun OT, Neumann K, Andreassen BK (2025)
Real-world comparison of pembrolizumab alone and combined with chemotherapy in metastatic lung adenocarcinoma patients with PD-L1 expression ≥50
ESMO Open, 10 (5), 105073
DOI 10.1016/j.esmoop.2025.105073, PubMed 40305908